Clinical trial
Omalizumab in Patients With Refractory Nasal Polyp
NCT05405478 is registered in ClinicalTrials.gov with Shiraz University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Omalizumab in Patients With Refractory Nasal Polyp
- Lead sponsor
- Shiraz University of Medical Sciences
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 1, 2022
- Completion date
- January 23, 2023
- Enrollment
- 2 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.